Holen Sie sich die Stockscreener-App
1.79
1.10%
-0.02
Schlusskurs vom Vortag:
$1.81
Offen:
$1.7833
24-Stunden-Volumen:
65,722
Relative Volume:
0.52
Marktkapitalisierung:
$50.71M
Einnahmen:
$48.20M
Nettoeinkommen (Verlust:
$-35.05M
KGV:
-1.1421
EPS:
-1.5673
Netto-Cashflow:
$-13.02M
1W Leistung:
-11.39%
1M Leistung:
+1.13%
6M Leistung:
-10.95%
1J Leistung:
-23.50%
1-Tages-Spanne:
$1.71
$1.8332
1-Wochen-Bereich:
$1.71
$2.0136
52-Wochen-Spanne:
$1.06
$4.35
Celularity Inc Stock (CELU) Company Profile
Firmenname
Celularity Inc
Sektor
Branche
Telefon
(908) 768-2170
Adresse
170 PARK AVE, FLORHAM PARK
Vergleichen Sie CELU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
1.79 | 51.28M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-30 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-06 | Herabstufung | Truist | Buy → Hold |
| 2022-01-28 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Celularity Inc Aktie (CELU) Neueste Nachrichten
Celularity receives FDA warning over marketing claims - MSN
Celularity Shares Face Persistent Headwinds Amid Regulatory and Financial Challenges - AD HOC NEWS
Celularity Receives FDA Warning Over Marketing Claims - TipRanks
Celularity Inc Receives FDA Warning Letter - TradingView
Is Celularity Inc. Equity Warrant stock attractive for ETFsTrade Volume Report & Growth Oriented Trade Recommendations - Newser
Will Celularity Inc. Equity Warrant stock benefit from commodity pricesWeekly Gains Summary & Growth Focused Stock Reports - Newser
Is Celularity Inc. Equity Warrant stock positioned for digital transformationMarket Performance Summary & Technical Confirmation Trade Alerts - Newser
Why analysts upgrade Celularity Inc. stockForecast Cut & Free Technical Pattern Based Buy Signals - Newser
Is Celularity Inc. Equity Warrant stock a safe investment in uncertain markets - Newser
Celularity (CELU) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Celularity Inc. (CELU) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
CELU announces CFO termination; appoints interim incharge - MSN
Celularity, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
[Form 4] Celularity Inc Insider Trading Activity - Stock Titan
Form 4: Celularity (CELU) director now holds 248,765 Class A shares - Stock Titan
Is Celularity Inc. Equity Warrant stock attractive after correctionWeekly Trading Summary & Expert Verified Movement Alerts - newser.com
Will Celularity Inc. Equity Warrant stock attract more institutional investors - newser.com
Is Celularity Inc a good long term investmentLarge Cap Stability Picks & Accelerated Capital Growth - earlytimes.in
Chart based analysis of Celularity Inc. Equity Warrant trendsQuarterly Profit Report & Safe Capital Preservation Plans - newser.com
Will Celularity Inc. Equity Warrant stock maintain momentum in 20252025 Year in Review & Real-Time Stock Entry Alerts - newser.com
Quantitative breakdown of Celularity Inc. Equity Warrant recent moveQuarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com
Using data models to predict Celularity Inc. Equity Warrant stock movementTrade Entry Report & AI Enhanced Trading Alerts - newser.com
Can Celularity Inc. Equity Warrant stock beat market expectations this quarterMarket Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Backtesting results for Celularity Inc. trading strategiesWeekly Profit Report & Long-Term Capital Growth Ideas - newser.com
Should you wait for a breakout in Celularity Inc.Insider Selling & Technical Pattern Based Buy Signals - newser.com
What analysts say about Celularity Inc stockSector Leadership Analysis & Ride the Wave of Market-Beating Growth - earlytimes.in
What does recent volatility data suggest for Celularity Inc.Forecast Cut & High Accuracy Trade Alerts - newser.com
Is Celularity Inc. Equity Warrant stock attractive for long term wealth buildingWeekly Trend Recap & Capital Efficiency Focused Ideas - newser.com
LEVIEN VINCENT Insider Trades - Nasdaq
How to use a screener to detect Celularity Inc. Equity Warrant breakoutsJuly 2025 PostEarnings & Fast Entry Momentum Trade Alerts - newser.com
What momentum shifts mean for Celularity Inc. Equity WarrantTrade Signal Summary & Technical Pattern Based Signals - newser.com
How to interpret RSI for Celularity Inc. Equity Warrant stockRecession Risk & Trade Opportunity Analysis - newser.com
Finanzdaten der Celularity Inc-Aktie (CELU)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):